EMEA-003202-PIP01-22 - paediatric investigation plan

Botulinum toxin type A
PIPHuman

Key facts

Active substance
Botulinum toxin type A
Therapeutic area
Other
Decision number
P/0233/2022
PIP number
EMEA-003202-PIP01-22
Pharmaceutical form(s)
All pharmaceutical forms
Condition(s) / indication(s)
Treatment of skin wrinkling
Route(s) of administration
All routes of administration
Contact for public enquiries

Galderma International S.A.S.

E-mail: info@galderma.com

Tel. +41 584558592

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Compliance check done
No

Decision

Share this page